{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:56:16Z","timestamp":1793321776751,"version":"4.5.0"},"reference-count":97,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>It is held that the condition of endogenous chronic hypersecretion of cortisol (Cushing syndrome, CS), causes several comorbidities, including cardiovascular and metabolic disorders, musculoskeletal alterations, as well as cognitive and mood impairment. Therefore, CS has an adverse impact on the quality of life and life expectancy of affected patients. What remains unclear is whether disease remission may induce a normalization of the associated comorbid conditions. In order to retrieve updated information on this issue, we conducted a systematic search using the Pubmed and Embase databases to identify scientific papers published from January 1, 2000, to December 31, 2022. The initial search identified 1907 potentially eligible records. Papers were screened for eligibility and a total of 79 were included and classified by the main topic (cardiometabolic risk, thromboembolic disease, bone impairment, muscle damage, mood disturbances and quality of life, cognitive impairment, and mortality).<\/jats:p>\n                  <jats:p>Although the limited patient numbers in many studies preclude definitive conclusions, most recent evidence supports the persistence of increased morbidity and mortality even after long-term remission. It is conceivable that the degree of normalization of the associated comorbid conditions depends on individual factors and characteristics of the conditions. These findings highlight the need for early recognition and effective management of patients with CS, which should include active treatment of the related comorbid conditions. In addition, it is important to maintain a surveillance strategy in all patients with CS, even many years after disease remission, and to actively pursue specific treatment of comorbid conditions beyond cortisol normalization.<\/jats:p>","DOI":"10.1210\/clinem\/dgad453","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T18:09:11Z","timestamp":1691086151000},"page":"e901-e919","source":"Crossref","is-referenced-by-count":53,"title":["Long-Term Consequences of Cushing Syndrome: A Systematic Literature Review"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2883-6139","authenticated-orcid":false,"given":"Soraya","family":"Puglisi","sequence":"first","affiliation":[{"name":"Internal Medicine, San Luigi Hospital, Department of Clinical and Biological Sciences, University of Turin , 10043 Orbassano , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria Elena","family":"Perini","sequence":"additional","affiliation":[{"name":"Internal Medicine, San Luigi Hospital, Department of Clinical and Biological Sciences, University of Turin , 10043 Orbassano , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Botto","sequence":"additional","affiliation":[{"name":"Internal Medicine, San Luigi Hospital, Department of Clinical and Biological Sciences, University of Turin , 10043 Orbassano , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Oliva","sequence":"additional","affiliation":[{"name":"Clinical Psychology Unit, Department of Clinical and Biological Sciences, University Hospital \u201cCitt\u00e0 della Salute e della Scienza di Torino\u201d, University of Turin , 10126 Turin , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4171-2851","authenticated-orcid":false,"given":"Massimo","family":"Terzolo","sequence":"additional","affiliation":[{"name":"Internal Medicine, San Luigi Hospital, Department of Clinical and Biological Sciences, University of Turin , 10043 Orbassano , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"issue":"7","key":"2024022001133944900_dgad453-B1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024022001133944900_dgad453-B2","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2024022001133944900_dgad453-B3","author":"Puglisi"},{"issue":"2","key":"2024022001133944900_dgad453-B4","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2024022001133944900_dgad453-B5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000486002","article-title":"Metabolic syndrome in Cushing's syndrome patients","volume":"49","author":"Ferra\u00f9","year":"2018","journal-title":"Front Horm Res"},{"issue":"4","key":"2024022001133944900_dgad453-B6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ecl.2019.08.005","article-title":"Hypertension and cardiovascular mortality in patients with Cushing syndrome","volume":"48","author":"Nieman","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"2024022001133944900_dgad453-B7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF03347198","article-title":"Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients","volume":"28","author":"Iacobone","year":"2005","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2024022001133944900_dgad453-B8","first-page":"439","article-title":"Effect of hypercortisolism control on high blood pressure in Cushing's syndrome","volume":"67","author":"Gomez","year":"2007","journal-title":"Medicina (B Aires)"},{"issue":"1","key":"2024022001133944900_dgad453-B9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/EJE-13-0555","article-title":"Surgical remission of Cushing's syndrome reduces cardiovascular risk","volume":"171","author":"Terzolo","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024022001133944900_dgad453-B10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12020-018-1819-6","article-title":"Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission","volume":"64","author":"Schernthaner-Reiter","year":"2019","journal-title":"Endocrine"},{"issue":"3","key":"2024022001133944900_dgad453-B11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2012-3547","article-title":"Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing's syndrome","volume":"98","author":"Barahona","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024022001133944900_dgad453-B12","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","article-title":"Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome","volume":"94","author":"Barahona","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024022001133944900_dgad453-B13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/cen.12639","article-title":"Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of Cushing's syndrome","volume":"82","author":"Wagenmakers","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024022001133944900_dgad453-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-14-0747","article-title":"Body composition and bone mineral density in women with Cushing's syndrome in remission and the association with common genetic variants influencing glucocorticoid sensitivity","volume":"172","author":"Ragnarsson","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2024022001133944900_dgad453-B15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/s-0030-1255032","article-title":"Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids","volume":"42","author":"Resmini","year":"2010","journal-title":"Horm Metab Res"},{"issue":"1","key":"2024022001133944900_dgad453-B16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11102-014-0566-9","article-title":"Soluble TNF\u03b1-receptor 1 as a predictor of coronary calcifications in patients after long-term cure of Cushing's syndrome","volume":"18","author":"Barahona","year":"2015","journal-title":"Pituitary"},{"issue":"11","key":"2024022001133944900_dgad453-B17","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1210\/jc.2016-1674","article-title":"Vascular health in patients in remission of Cushing's syndrome is comparable with that in BMI-matched controls","volume":"101","author":"Wagenmakers","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024022001133944900_dgad453-B18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jc.2012-2893","article-title":"Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients","volume":"98","author":"Lambert","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024022001133944900_dgad453-B19","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024022001133944900_dgad453-B20","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1210\/clinem\/dgaa291","article-title":"Excess morbidity persists in patients with Cushing's disease during long-term remission: a Swedish nationwide study","volume":"105","author":"Papakokkinou","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024022001133944900_dgad453-B21","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","article-title":"Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study","volume":"96","author":"Stuijver","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024022001133944900_dgad453-B22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/cen.13521","article-title":"Translational evidence of prothrombotic and inflammatory endothelial damage in Cushing syndrome after remission","volume":"88","author":"Aranda","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2024022001133944900_dgad453-B23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40618-021-01605-5","article-title":"Evaluation of procoagulant imbalance in Cushing's syndrome after short- and long-term remission of disease","volume":"45","author":"Ferrante","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2024022001133944900_dgad453-B24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/cen.12812","article-title":"Bone density and microarchitecture in endogenous hypercortisolism","volume":"83","author":"dos Santos","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2024022001133944900_dgad453-B25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00198-013-2520-5","article-title":"Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants","volume":"25","author":"Trementino","year":"2014","journal-title":"Osteoporos Int"},{"issue":"1","key":"2024022001133944900_dgad453-B26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/eje.1.02067","article-title":"Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study","volume":"154","author":"Kristo","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2024022001133944900_dgad453-B27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/EJE-21-0226","article-title":"Persistent improvement of bone mineral density up to 20 years after treatment of Cushing's syndrome","volume":"185","author":"van Houten","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2024022001133944900_dgad453-B28","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1359\/jbmr.090505","article-title":"Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome","volume":"24","author":"Barahona","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024022001133944900_dgad453-B29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11102-011-0306-3","article-title":"Spontaneous recovery of bone mass after cure of endogenous hypercortisolism","volume":"15","author":"Randazzo","year":"2012","journal-title":"Pituitary"},{"issue":"1","key":"2024022001133944900_dgad453-B30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1460051","article-title":"Increased risk of osteoporotic fractures in patients with Cushing's syndrome","volume":"146","author":"Vestergaard","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2024022001133944900_dgad453-B31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1530\/EJE-16-0689","article-title":"Persistence of myopathy in Cushing's syndrome: evaluation of the German Cushing's registry","volume":"176","author":"Berr","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2024022001133944900_dgad453-B32","doi-asserted-by":"crossref","first-page":"e4490","DOI":"10.1210\/clinem\/dgaa625","article-title":"Persisting muscle dysfunction in Cushing's syndrome despite biochemical remission","volume":"105","author":"Vogel","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024022001133944900_dgad453-B33","doi-asserted-by":"crossref","first-page":"e1408","DOI":"10.1210\/clinem\/dgz286","article-title":"Decreased aerobic exercise capacity after long-term remission from Cushing syndrome: exploration of mechanisms","volume":"105","author":"Roerink","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024022001133944900_dgad453-B34","doi-asserted-by":"crossref","first-page":"e2039","DOI":"10.1210\/clinem\/dgz329","article-title":"Thigh muscle fat infiltration is associated with impaired physical performance despite remission in Cushing's syndrome","volume":"105","author":"Martel-Duguech","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024022001133944900_dgad453-B35","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1210\/clinem\/dgab079","article-title":"Psychotropic drugs in patients with Cushing's disease before diagnosis and at long-term follow-up: A nationwide study","volume":"106","author":"Bengtsson","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024022001133944900_dgad453-B36","first-page":"117","article-title":"Incidence and late prognosis of Cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024022001133944900_dgad453-B37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2005-1058","article-title":"Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission","volume":"91","author":"Lindsay","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024022001133944900_dgad453-B38","doi-asserted-by":"crossref","first-page":"E1640","DOI":"10.1210\/jc.2012-1945","article-title":"Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission","volume":"97","author":"Ragnarsson","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024022001133944900_dgad453-B39","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","article-title":"Quality of life in patients after long-term biochemical cure of Cushing's disease","volume":"90","author":"van Aken","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2024022001133944900_dgad453-B40","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.934347","article-title":"Impaired quality of life, but not cognition, is linked to a history of chronic hypercortisolism in patients with Cushing's disease in remission","volume":"13","author":"Pupier","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2024022001133944900_dgad453-B41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-12-0308","article-title":"Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?","volume":"167","author":"Wagenmakers","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2024022001133944900_dgad453-B42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2265.2004.02118.x","article-title":"Long-term negative impact on quality of life in patients with successfully treated Cushing's disease","volume":"61","author":"Heald","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2024022001133944900_dgad453-B43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/EJE-16-0779","article-title":"Affective alterations in patients with Cushing's syndrome in remission are associated with decreased BDNF and cortisone levels","volume":"176","author":"Valassi","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2024022001133944900_dgad453-B44","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1210\/jc.2010-0512","article-title":"Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024022001133944900_dgad453-B45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.psyneuen.2017.05.010","article-title":"Decreased prefrontal functional brain response during memory testing in women with Cushing's syndrome in remission","volume":"82","author":"Ragnarsson","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"2024022001133944900_dgad453-B46","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/173653","article-title":"Mental fatigue and executive dysfunction in patients with Cushing's syndrome in remission","volume":"2015","author":"Papakokkinou","year":"2015","journal-title":"Behav Neurol"},{"issue":"6","key":"2024022001133944900_dgad453-B47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EJE-13-0471","article-title":"Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study","volume":"169","author":"Andela","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2024022001133944900_dgad453-B48","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.nicl.2014.01.017","article-title":"Widespread reductions of white matter integrity in patients with long-term remission of Cushing's disease","volume":"4","author":"van der Werff","year":"2014","journal-title":"Neuroimage Clin"},{"key":"2024022001133944900_dgad453-B49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.psyneuen.2015.05.001","article-title":"Altered neural processing of emotional faces in remitted Cushing's disease","volume":"59","author":"Bas-Hoogendam","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"2024022001133944900_dgad453-B50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41398-020-00980-6","article-title":"Cortical thickness abnormalities in long-term remitted Cushing's disease","volume":"10","author":"Bauduin","year":"2020","journal-title":"Transl Psychiatry"},{"issue":"3","key":"2024022001133944900_dgad453-B51","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11102-017-0793-y","article-title":"White matter involvement on DTI-MRI in Cushing's syndrome relates to mood disturbances and processing speed: a case-control study","volume":"20","author":"Pires","year":"2017","journal-title":"Pituitary"},{"issue":"2","key":"2024022001133944900_dgad453-B52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000338408","article-title":"Increased prevalence of anxiety-associated personality traits in patients with Cushing's disease: a cross-sectional study","volume":"97","author":"Dimopoulou","year":"2013","journal-title":"Neuroendocrinology"},{"issue":"3","key":"2024022001133944900_dgad453-B53","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/cen.12521","article-title":"Predictors of quality of life in 102 patients with treated Cushing's disease","volume":"82","author":"Carluccio","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2024022001133944900_dgad453-B54","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4183\/aeb.2019.482","article-title":"Are there reliable predictors for the impaired quality of life in patients with Cushing's syndrome?","volume":"15","author":"Nankova","year":"2019","journal-title":"Acta Endocrinol (Buchar)"},{"issue":"1","key":"2024022001133944900_dgad453-B55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-17-0048","article-title":"Health-related quality of life of patients with hypothalamic-pituitary-adrenal axis dysregulations: a cohort study","volume":"177","author":"De Bucy","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2024022001133944900_dgad453-B56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-18-0212","article-title":"Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up","volume":"179","author":"Osswald","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024022001133944900_dgad453-B57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4158\/EP15855.OR","article-title":"Patients' perception on clinical outcome and quality of life after a diagnosis of Cushing syndrome","volume":"22","author":"Papoian","year":"2016","journal-title":"Endocr Pract"},{"issue":"1","key":"2024022001133944900_dgad453-B58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ando.2018.01.002","article-title":"Bilateral adrenalectomy in Cushing's disease: altered long-term quality of life compared to other treatment options","volume":"80","author":"Sarkis","year":"2019","journal-title":"Ann Endocrinol (Paris)"},{"issue":"4","key":"2024022001133944900_dgad453-B59","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-11-0307","article-title":"Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome","volume":"165","author":"Tiemensma","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2024022001133944900_dgad453-B60","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1210\/jc.2010-2490","article-title":"Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas","volume":"96","author":"Tiemensma","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024022001133944900_dgad453-B61","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s11102-016-0750-1","article-title":"Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease","volume":"19","author":"Siegel","year":"2016","journal-title":"Pituitary"},{"issue":"1","key":"2024022001133944900_dgad453-B62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0090-3019(99)00197-4","article-title":"Cerebral atrophy in Cushing's disease","volume":"53","author":"Simmons","year":"2000","journal-title":"Surg Neurol"},{"issue":"2","key":"2024022001133944900_dgad453-B63","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1210\/jc.2011-2231","article-title":"Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome","volume":"97","author":"Resmini","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024022001133944900_dgad453-B64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1530\/EJE-14-0371","article-title":"Small cerebellar cortex volume in patients with active Cushing's syndrome","volume":"171","author":"Santos","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2024022001133944900_dgad453-B65","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1530\/EC-21-0385","article-title":"Trends in regional morphological changes in the brain after the resolution of hypercortisolism in Cushing's disease: a complex phenomenon, not mere partial reversibility","volume":"10","author":"Jiang","year":"2021","journal-title":"Endocr Connect"},{"key":"2024022001133944900_dgad453-B66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116769","article-title":"The aging-liked alterations in Cushing's disease: A neurite orientation dispersion and density imaging (NODDI) study","volume":"413","author":"Jiang","year":"2020","journal-title":"J Neurol Sci"},{"issue":"5","key":"2024022001133944900_dgad453-B67","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/cen.12224","article-title":"Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MR-spectroscopy","volume":"79","author":"Resmini","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024022001133944900_dgad453-B68","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105334","article-title":"Potential associations between immune signaling genes, deactivated microglia, and oligodendrocytes and cortical gray matter loss in patients with long-term remitted Cushing's disease","volume":"132","author":"Bauduin","year":"2021","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"2024022001133944900_dgad453-B69","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/EJE-20-1139","article-title":"Imaging cerebral microbleeds in Cushing's disease evaluated by quantitative susceptibility mapping: an observational cross-sectional study","volume":"184","author":"Jiang","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2024022001133944900_dgad453-B70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/cen.13277","article-title":"Altered spontaneous brain activity in Cushing's disease: a resting-state functional MRI study","volume":"86","author":"Jiang","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2024022001133944900_dgad453-B71","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/npp.2015.38","article-title":"Resting-state functional connectivity in patients with long-term remission of Cushing's disease","volume":"40","author":"van der Werff","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"2024022001133944900_dgad453-B72","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-19-0028","article-title":"Elevated resting-state connectivity in the medial temporal lobe and the prefrontal cortex among patients with Cushing's syndrome in remission","volume":"180","author":"Stomby","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"2024022001133944900_dgad453-B73","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1055\/s-2006-924332","article-title":"A cross-sectional study to investigate long-term cognitive function in people with treated pituitary Cushing's disease","volume":"114","author":"Heald","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"2024022001133944900_dgad453-B74","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jc.2009-2032","article-title":"Subtle cognitive impairments in patients with long-term cure of Cushing's disease","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024022001133944900_dgad453-B75","doi-asserted-by":"crossref","first-page":"E1803","DOI":"10.1210\/jc.2014-1906","article-title":"Common genetic variants in the glucocorticoid receptor and the 11beta-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing's syndrome in remission","volume":"99","author":"Ragnarsson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024022001133944900_dgad453-B76","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1210\/jc.2003-032180","article-title":"Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results","volume":"89","author":"Hammer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024022001133944900_dgad453-B77","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2011.04124.x","article-title":"Mortality and morbidity in Cushing's syndrome in New Zealand","volume":"75","author":"Bolland","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2024022001133944900_dgad453-B78","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/jc.2011-2957","article-title":"Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years","volume":"97","author":"Hassan-Smith","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024022001133944900_dgad453-B79","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-13-0569","article-title":"Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up","volume":"169","author":"Ntali","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2024022001133944900_dgad453-B80","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1210\/jc.2006-2112","article-title":"Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma","volume":"92","author":"Dekkers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024022001133944900_dgad453-B81","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1530\/EJE-13-0320","article-title":"Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center","volume":"169","author":"Yaneva","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2024022001133944900_dgad453-B82","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with Cushing disease: A Swedish nationwide study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024022001133944900_dgad453-B83","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2024022001133944900_dgad453-B84","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac045","article-title":"Increased mortality persists after treatment of Cushing's disease: a matched nationwide cohort study","volume":"6","author":"Bengtsson","year":"2022","journal-title":"J Endocr Soc"},{"issue":"1","key":"2024022001133944900_dgad453-B85","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1210\/clinem\/dgaa774","article-title":"Diabetes, active disease, and afternoon serum cortisol levels predict Cushing's disease mortality: a cohort study","volume":"106","author":"Rold\u00e1n-Sarmiento","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024022001133944900_dgad453-B86","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.12094","article-title":"Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment","volume":"78","author":"van der Pas","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2024022001133944900_dgad453-B87","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/EJE-15-0308","article-title":"Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect","volume":"173","author":"Isidori","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2024022001133944900_dgad453-B88","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101515","article-title":"Osteopathy in mild adrenal Cushing's syndrome and Cushing disease","volume":"35","author":"Frara","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"2024022001133944900_dgad453-B89","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/er.2018-00097","article-title":"Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy","volume":"39","author":"Hardy","year":"2018","journal-title":"Endocr Rev"},{"issue":"5","key":"2024022001133944900_dgad453-B90","doi-asserted-by":"crossref","first-page":"R139","DOI":"10.1530\/EJE-13-0534","article-title":"Cushing's syndrome: a structured short- and long-term management plan for patients in remission","volume":"169","author":"Ragnarsson","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2024022001133944900_dgad453-B91","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s11102-022-01245-9","article-title":"Quality of life impairment after a diagnosis of Cushing's syndrome","volume":"25","author":"Webb","year":"2022","journal-title":"Pituitary"},{"issue":"1","key":"2024022001133944900_dgad453-B92","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101521","article-title":"Epidemiology and mortality of Cushing's syndrome","volume":"35","author":"Hakami","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"2024022001133944900_dgad453-B93","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1097\/HJH.0000000000003252","article-title":"Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the working group on endocrine hypertension of the European Society of Hypertension","volume":"40","author":"Fallo","year":"2022","journal-title":"J Hypertens"},{"issue":"5","key":"2024022001133944900_dgad453-B94","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1530\/EJE-20-1309","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing's syndrome: a practical approach","volume":"184","author":"Varlamov","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"10296","key":"2024022001133944900_dgad453-B95","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(21)00536-5","article-title":"SGLT2 Inhibitors and GLP-1 receptor agonists: established and emerging indications","volume":"398","author":"Brown","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"2024022001133944900_dgad453-B96","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00198-013-2588-y","article-title":"Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?","volume":"25","author":"Scillitani","year":"2014","journal-title":"Osteoporos Int"},{"issue":"3","key":"2024022001133944900_dgad453-B97","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3803\/EnM.2021.1069","article-title":"Cushing syndrome associated myopathy: it is time for a change","volume":"36","author":"Reincke","year":"2021","journal-title":"Endocrinol Metab (Seoul)"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad453\/51075436\/dgad453.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/3\/e901\/56680786\/dgad453.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/3\/e901\/56680786\/dgad453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T20:17:29Z","timestamp":1708373849000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/3\/e901\/7236759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":97,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,8,3]]},"published-print":{"date-parts":[[2024,2,20]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad453","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,8,3]]}}}